TY - JOUR
T1 - Cancer- and noncancer-specific cumulative incidence of death after exposure to polychlorinated biphenyls and dioxins
T2 - A competing risk analysis among Yusho patients
AU - Onozuka, Daisuke
AU - Nakamura, Yuko
AU - Tsuji, Gaku
AU - Furue, Masutaka
N1 - Funding Information:
The authors express their sincere appreciation to Yuko Katsuno, Keiko Kajishima, Sachiyo Tadakuma, Mikiko Yamane, Yoshihito Kawakami, Naomi Nishizawa, and Kenichiro Miura, who greatly contributed to the management of the cohort data for the Yusho patients. The authors are also grateful to the staffs of the Ministry of Health, Labour and Welfare and prefectural and municipal government which contributed to the collection of follow-up data. This work was supported by the Ministry of Health, Labour and Welfare Research Grant Number H30-Shokuhin-Shitei-005. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or preparation of the manuscript. DO made substantial contributions to the conception and design of the study, analyzed and interpreted data and drafted the manuscript. YN, GT, and MF was involved in drafting the manuscript and critically revising it for important intellectual content.
Funding Information:
This work was supported by the Ministry of Health, Labour and Welfare Research Grant Number H30-Shokuhin-Shitei-005. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or preparation of the manuscript.
Publisher Copyright:
© 2020 The Author(s)
PY - 2021/2
Y1 - 2021/2
N2 - Background: In competing risks settings, the cause-specific cumulative incidence function is of great interest since it quantifies cumulative risk in the presence of other causes. To date, however, long-term cancer- and noncancer-specific mortality in Yusho patients exposed to polychlorinated biphenyls (PCBs) and dioxin-related compounds has not been estimated. Methods: We identified vital status and cause of death for Yusho patients between 1968 and 2017. Risk of cancer- and noncancer-specific mortality was estimated using a flexible hazards-based regression model, with accounting for competing events. Results: In total, 1664 Yusho patients with 63,566 person-years of follow-up were included in the analysis. 50-year cumulative incidence of cancer mortality was 12.4% (95% confidence interval [CI], 10.5–14.7) in males and 4.7% (95% CI, 3.5–6.4) in females (difference, 7.7 percentage points [95% CI, 5.2–10.2]; adjusted hazard ratio for males, 2.61 [95% CI, 1.93–3.52]). For noncancer, the 50-year cumulative incidence of mortality was 35.4% (95% CI, 32.8–38.3) in males and 35.6% (95% CI, 33.3–38.1) in females (difference, −0.2 percentage points [95% CI, −3.5 to 3.1]; adjusted hazard ratio for males, 1.51 [95% CI, 1.26–1.82]). Conclusions: These findings confirm that male Yusho patients have a significantly higher risk of cumulative incidence of cancer-specific mortality than female Yusho patients. Our findings might be useful in providing Yusho patients with more accurate information on cancer prognosis and survivorship and help determine more appropriate disease management.
AB - Background: In competing risks settings, the cause-specific cumulative incidence function is of great interest since it quantifies cumulative risk in the presence of other causes. To date, however, long-term cancer- and noncancer-specific mortality in Yusho patients exposed to polychlorinated biphenyls (PCBs) and dioxin-related compounds has not been estimated. Methods: We identified vital status and cause of death for Yusho patients between 1968 and 2017. Risk of cancer- and noncancer-specific mortality was estimated using a flexible hazards-based regression model, with accounting for competing events. Results: In total, 1664 Yusho patients with 63,566 person-years of follow-up were included in the analysis. 50-year cumulative incidence of cancer mortality was 12.4% (95% confidence interval [CI], 10.5–14.7) in males and 4.7% (95% CI, 3.5–6.4) in females (difference, 7.7 percentage points [95% CI, 5.2–10.2]; adjusted hazard ratio for males, 2.61 [95% CI, 1.93–3.52]). For noncancer, the 50-year cumulative incidence of mortality was 35.4% (95% CI, 32.8–38.3) in males and 35.6% (95% CI, 33.3–38.1) in females (difference, −0.2 percentage points [95% CI, −3.5 to 3.1]; adjusted hazard ratio for males, 1.51 [95% CI, 1.26–1.82]). Conclusions: These findings confirm that male Yusho patients have a significantly higher risk of cumulative incidence of cancer-specific mortality than female Yusho patients. Our findings might be useful in providing Yusho patients with more accurate information on cancer prognosis and survivorship and help determine more appropriate disease management.
UR - http://www.scopus.com/inward/record.url?scp=85097754157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097754157&partnerID=8YFLogxK
U2 - 10.1016/j.envint.2020.106320
DO - 10.1016/j.envint.2020.106320
M3 - Article
C2 - 33321390
AN - SCOPUS:85097754157
SN - 0160-4120
VL - 147
JO - Environmental International
JF - Environmental International
M1 - 106320
ER -